Non‐transferrin‐bound iron is present in serum of hereditary haemochromatosis heterozygotes
Authors:
- AddicksADAddicks
- I GosriwatanaIGI Gosriwatana
- S LuSLS Lu
- R C HiderRHR C Hider
- M. MarxMMM. Marx
- 1 March 2000
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 30 (3) , 248-251
Abstract
Background: Hereditary haemochromatosis (HH) is a common autosomal recessive disease. Recently, HH heterozygosity has been identified as an independent risk factor for myocardial infarction and cardiovascular mortality. Iron may play an important role in atherogenesis by catalyzing peroxidation of low‐density‐lipoprotein (LDL), an essential step in atherogenesis. In iron overload conditions, non‐transferrin‐bound iron (NTBI) is found in serum, which can catalyze lipid peroxidation. We investigated whether sera of HH heterozygotes contain more NTBI than sera of normal controls.Methods: In 27 treated HH homozygotes, 22 HH heterozygotes and 17 healthy control subjects, conventional parameters of iron status (serum iron, transferrin saturation, serum ferritin) were measured. NTBI was detected using HPLC after addition of nitrilotriacetic acid and pretreatment with cobalt.Results: The conventional parameters of iron status were similar in the HH heterozygous group and the control group. NTBI was significantly higher in homozygotes compared to heterozygotes (1.79 μmol L−1 vs. 0.51 μmol L−1, 95% CI of the difference = 0.6–1.95, P < 0.001), and controls (1.79 μmol L−1 vs. − 0.3 μmol L−1, 95% CI of the difference = 1.36–2.81, P < 0.001). The difference in NTBI between the heterozygous subjects and control subjects was also significant (0.51 μmol L−1 vs. − 0.3 μmol L−1, 95% CI of the difference = 0.05–1.57, P < 0.05).Conclusion: Phlebotomy treated HH homozygotes maintain a high and potentially harmful serum NTBI. HH heterozygotes have a higher serum NTBI than normal controls. The reported increased risk of cardiovascular events in heterozygous haemochromatosis may be explained by NTBI‐catalyzed LDL peroxidation.Keywords
This publication has 24 references indexed in Scilit:
- Iron and the Genetics of Cardiovascular DiseaseCirculation, 1999
- Increased Risk of Acute Myocardial Infarction in Carriers of the Hemochromatosis Gene Cys282Tyr MutationCirculation, 1999
- Iron Is Hot: An Update on the Pathophysiology of HemochromatosisBlood, 1998
- Mutations of the Hereditary Hemochromatosis Candidate GeneHLA-Hin Porphyria Cutanea TardaNew England Journal of Medicine, 1997
- Clinical and Biochemical Abnormalities in People Heterozygous for HemochromatosisNew England Journal of Medicine, 1996
- Haemochromatosis and HLA–HNature Genetics, 1996
- Haemochromatosis and HLA–HNature Genetics, 1996
- A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosisNature Genetics, 1996
- Case Report: Hemochromatosis Heterozygotes May Have Significant Iron Overload When They Also Have Hereditary SpherocytosisThe American Journal of the Medical Sciences, 1986
- Hereditary HemochromatosisNew England Journal of Medicine, 1979